| Patent Number |
Title Of Patent |
Date Issued |
| 6419925 |
Toxoplasma gondii antigens, the preparation thereof and the use thereof |
July 16, 2002 |
| The present invention relates to the identification of toxoplasma gondii antigens and the preparation thereof by genetic engineering. A cDNA expression gene bank of this parasite was prepared. Recombinant clones which are of diagnostic interest were identified using a high-titer rabbit |
| 6326008 |
Toxoplasma gondii antigens, the preparation thereof and the use thereof |
December 4, 2001 |
| The present invention relates to the identification of toxoplasma gondii antigens and the preparation thereof by genetic engineering. A cDNA expression gene bank of this parasite was prepared. Recombinant clones which are of diagnostic interest were identified using a high-titer rabbit |
| 6022546 |
Toxoplasma gondii antigens, the preparation thereof and the use thereof |
February 8, 2000 |
| The present invention relates to the identification of Toxoplasma gondii antigens and the preparation thereof by genetic engineering. A cDNA expression gene bank of this parasite was prepared. Recombinant clones which are of diagnostic interest were identified using a high-titer rabbit |
| 5585268 |
Malaria-specific DNA sequences, expression products thereof, and the use thereof |
December 17, 1996 |
| The invention relates to malaria-specific nucleic acid sequences, to the expression products thereof, and to the use thereof. A combination of three of the expression proteins whose nucleic acid sequences were isolated by screening a lambda gt11 gene bank with a monospecific antiseru |
| 5457089 |
Muteins of human erythropoietin, the preparation thereof and the use thereof |
October 10, 1995 |
| The invention relates to muteins of human erythropoietin (EPO) in the carboxyl terminal region which are prepared by means of recombinant DNA techniques. These mutants have advantageous properties in comparison with human wild-type EPO. |
| 5395614 |
Protective Plasmodium falciparum hybrid proteins which contain part-sequences of the malaria ant |
March 7, 1995 |
| Protective Plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof.The invention relates to hybrid proteins composed of part-sequences of the malaria antigens HRPII and SERP. The HRPII sequence has already |
| 5393523 |
Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II |
February 28, 1995 |
| Recombinant histidine-rich protein of Plasmodium falciparum, its preparation and use. It was possible, by screening two different Plasmodium falciparum cDNA gene banks with an antiserum against a 41 kD protein and by cross-hybridization with the insert DNA of a clone obtained therewi |
| 5194587 |
Malaria-specific DNA sequences, expression products thereof, and the use thereof |
March 16, 1993 |
| The invention relates to malaria-specific DNA sequences, to the expression products thereof, and to the use thereof.A combination of three of the expression proteins whose DNA sequences were isolated by screening a lambda gt11 gene bank with a monospecific antiserum against the protectiv |
